Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MYRX:US

0.1198 USD 0.00000.00%

As of 20:10:06 ET on 04/20/2015.

Company Profile for Myrexis Inc (MYRX)

Myrexis Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel small molecule drugs for the treatment of cancer. Myriad's pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures.

Contact Information

Myrexis Inc

305 Chipeta Way
Salt Lake City, UT 84108
United States
Phone: 1-801-214-7800
Fax: 1-801-214-7992

Key Executives for Myrexis Inc (MYRX)

Jonathan M CouchmanChairman/President/CEO/CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil